Jacek Glajzer

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Expression of the immune checkpoint CD137/CD137L in oral squamous cell carcinoma (OSCC) and association with histopathological parameters.

Expression of the immune checkpoint CD137/CD137L in oral squamous cell carcinoma (OSCC) and association with histopathological parameters.

Journal: Virchows Archiv : an international journal of pathology

Published: October 17, 2025

Characterization of exceptional responders with long-term PARP inhibitor therapy in recurrent ovarian cancer: an analysis of 23 patients from Charité.

Characterization of exceptional responders with long-term PARP inhibitor therapy in recurrent ovarian cancer: an analysis of 23 patients from Charité.

Journal: Archives of gynecology and obstetrics

Published: October 08, 2025

Investigation of the CTLA-4-CD28 Axis in Oral Squamous Cell Carcinoma.

Investigation of the CTLA-4-CD28 Axis in Oral Squamous Cell Carcinoma.

Journal: Journal of clinical medicine

Published: May 20, 2025

Digital analysis of the human maxilla to enable semistandardized template tool reconstructions with free fibula transplants.

Digital analysis of the human maxilla to enable semistandardized template tool reconstructions with free fibula transplants.

Journal: Clinical oral investigations

Published: June 22, 2024

The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?

The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?

Journal: Cancers

Published: March 11, 2023

Real-World Evidence: How Long Do Our Patients Fast?-Results from a Prospective JAGO-NOGGO-Multicenter Analysis on Perioperative Fasting in 924 Patients with Malignant and Benign Gynecological Diseases.

Real-World Evidence: How Long Do Our Patients Fast?-Results from a Prospective JAGO-NOGGO-Multicenter Analysis on Perioperative Fasting in 924 Patients with Malignant and Benign Gynecological Diseases.

Journal: Cancers

Published: January 07, 2023

Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature.

Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature.

Journal: Frontiers in immunology

Published: June 16, 2022

Beyond PD-L1-Identification of Further Potential Therapeutic Targets in Oral Cancer.

Beyond PD-L1-Identification of Further Potential Therapeutic Targets in Oral Cancer.

Journal: Cancers

Published: February 28, 2022

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Journal: Annals of surgical oncology

Published: September 30, 2021

Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological Response.

Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological Response.

Journal: Frontiers in oncology

Published: June 05, 2021

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Journal: British journal of cancer

Published: February 18, 2018

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 15, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026